Scott P. Bruder - 31 Dec 2021 Form 4 Insider Report for Bellerophon Therapeutics, Inc. (BLPH)

Role
Director
Signature
/s/ Scott Bruder
Issuer symbol
BLPH
Transactions as of
31 Dec 2021
Transactions value $
$67,667
Form type
4
Filing time
04 Jan 2022, 15:10:26 UTC
Next filing
14 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLPH Stock Options (right to buy) Award $67,666 +21,828 +144% $3.1* 36,966 31 Dec 2021 Common Stock 21,828 $3.1 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.